1 / 13

Thromboprophylaxis in the paediatric setting

Thromboprophylaxis in the paediatric setting. Background. No evidence for routine VTE risk assessment No evidence to support the routine use of thromboprophylaxis, mechanical or pharmacological. Incidence. VTE rarely occurs in the paediatric population

luce
Télécharger la présentation

Thromboprophylaxis in the paediatric setting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thromboprophylaxis in the paediatric setting

  2. Background • No evidence for routine VTE risk assessment • No evidence to support the routine use of thromboprophylaxis, mechanical or pharmacological

  3. Incidence • VTE rarely occurs in the paediatric population • Incidence 0.7-1.0 per 100,000 population • Peak incidence in neonates and adolescents • Prevalence 5.3 per 10,000 hospital admissions.

  4. Recommendations of best practice • Early mobilisation • Adequate hydration • Prompt removal of central venous lines • Consider site of insertion of CVL (Femoral vein is associated with highest incidence of thrombosis)

  5. Contributing factors • Majority of VTEs are catheter related or have multiple underlying contributing factors such as • Sepsis • Immobility • Malignancy • Surgery • Congenital heart disease • Trauma Ca

  6. When to seek advice • If multiple contributing factors are present seek advice from paediatric consultant or paediatric haematologist to consider the risk benefit ratio of using thromboprophylaxis BCSH guideline “Investigation, management, and prevention of VTE in children

  7. Scenario 1 • 14 year old girl, newly diagnosed leukaemia, neutropenic sepsis, bed-bound, dehydrated • What VTE prophylaxis does she require?

  8. Scenario 1 Answer • 14 year old girl, newly diagnosed leukaemia, neutropenic sepsis, bed-bound, dehydrated • Follow recommendations of best practice, and seek specialist advice.

  9. Scenario 2 • 14 year old boy with inflamed appendix, no other contributing factors for VTE • What VTE prophylaxis does he require?

  10. Scenario 2 Answer • 14 year old boy with inflamed appendix, no other contributing factors for VTE • Follow recommendations of best practice, no other prophylactic measures required.

  11. Scenario 3 • 15 year old girl, newly diagnosed sarcoma compressing pelvic and iliac vessels, bed-bound, dehydrated • What VTE prophylaxis does she require?

  12. Scenario 3 Answer • 15 year old girl, newly diagnosed sarcoma compressing pelvic and iliac vessels, bed-bound, dehydrated • Follow recommendations of best practice, and seek specialist advice.

  13. Certificate Thromboprophylaxis in the paediatric setting Completed by ………………………………….. On ……………..

More Related